Some have speculated that pulmonary arterial hypertension-specific medication such as ET-1 antagonists that mediates pulmonary vasodilation and anti-proliferation and is anti-thrombotic may offer a protective benefit against SARS-CoV-2 [57]. This evidence concerns the gene EDN1 and pulmonary arterial hypertension.